Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
2.060
-0.015 (-0.72%)
At close: Jun 9, 2025, 4:00 PM
2.110
+0.050 (2.43%)
After-hours: Jun 9, 2025, 6:14 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $7.03 million as of June 9, 2025. Its market cap has decreased by -45.07% in one year.
Market Cap
7.03M
Enterprise Value
4.07M
1-Year Change
-45.07%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $7.03M, a decrease of -87.99%. That is a compound annual growth rate of -44.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2025 | 7.03M | -51.68% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.15B |
| Johnson & Johnson | 373.01B |
| AbbVie | 335.32B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.06B |
| Abbott Laboratories | 232.41B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |